famotidine has been researched along with Esophageal Diseases in 3 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "93 patients (19%) were treated for abdominal pain where no diagnosis had been reached or who had only a diagnosis of gastritis on endoscopy." | 1.29 | Long term acid suppressing treatment in general practice. ( Jacyna, MR; Levi, AJ; Miller, RJ; O'Reilly, S; Ross, J; Ryder, SD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shiratori, K | 1 |
| Watanabe, S | 1 |
| Maruyama, M | 1 |
| Adachi, H | 1 |
| Itoh, Y | 1 |
| Kurokawa, K | 1 |
| Takeuchi, T | 1 |
| Ryder, SD | 1 |
| O'Reilly, S | 1 |
| Miller, RJ | 1 |
| Ross, J | 1 |
| Jacyna, MR | 1 |
| Levi, AJ | 1 |
| Miehsler, W | 1 |
| Püspök, A | 1 |
| Oberhuber, T | 1 |
| Vogelsang, H | 1 |
3 other studies available for famotidine and Esophageal Diseases
| Article | Year |
|---|---|
[A case of refractory chronic Zollinger-Ellison syndrome--treated successfully with famotidine].
Topics: Chronic Disease; Esophageal Diseases; Esophagogastric Junction; Famotidine; Histamine H2 Antagonists | 1984 |
Long term acid suppressing treatment in general practice.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 1994 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |